Atlas Trials

Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome

Clinical trial NCT04783675 · COMPLETED

Trial details

NCT number
NCT04783675
Sponsor
Children's Hospital of Fudan University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Steroid-Sensitive Nephrotic Syndrome
Start date
2021-04-13
Primary completion
2023-01-17
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.